Global Transthyretin Amyloidosis (ATTR) Market: Industry Analysis & Outlook (2018-2025)

1
Industry Research by Koncept Analytics
Global ATTR Market Industry Analysis Outlook
-----------------------------------------
(2018-2025)
July 2017
2
Executive Summary
ATTR amyloidosis, A for Amyloid and the TTR is an
abbreviation used for the protein
transthyretin. ATTR amyloidosis is a rare
disease, caused by the build-up of abnormal
protein deposits in various tissues of the body.
Amyloid deposits cause disorder by damaging the
structure and the function of the organs where
they are found and they can affect almost any
part of the body. There are three different types
of ATTR Amyloidosis Familial Amyloid
Polyneuropathy (FAP), which affects the nervous
system, often the heart and sometimes the kidneys
and eyes. Second is, Familial Amyloid
Cardiomyopathy (FAC), which is a hereditary,
genetic condition, caused by mutations in the TTR
gene resulting in production of the abnormal TTR
and the last is, Senile Systemic Amyloidosis
(SSA) which is not hereditary and a slowly
progressive disease. It is far more prevalent in
men than in women. Methods to diagnose ATTR
include tissue biopsy, genetic testing and
imaging studies of the heart. Currently, there
are no higher efficacy ATTR drugs available in
the market, but they are expected to hit the
market by 2018. The potential ATTR drug
candidates include Patisiran and IONIS-TTRrx. For
now, off-label drugs and therapies are employed
to counter the progression of ATTR. The global
ATTR market is expected to experience robust
growth post the launch of ATTR therapeutic drugs,
primarily due to increasing African-American
population, increasing health care expenditure
and accelerating economic growth. However, the
growth of this budding market is is hindered by
the stringent regulations, high cost of ATTR
drugs, misdiagnosis of ATTR disorder and
limitation of clinical trials. The report Global
ATTR Market Industry Analysis Outlook
(2018-2025) analyzes the development of this
market, with focus on the U.S. and Europe
markets. The major trends, growth drivers as well
as issues being faced by the market are discussed
in detail in this report. The four major players
Pfizer Inc., Ionis Pharmaceuticals Inc., Alnylam
Pharmaceuticals Inc. and Prothena Corporation
Plc. are being profiled along with their key
financials and strategies for growth. The report
contains a comprehensive analysis of the global
ATTR market along with the study of the regional
markets.
3
Rising African-American population and increasing
health care expenditure supported the growth of
ATTR market.
Global ATTR Market Forecast by Value
(2018-2025)

• The global ATTR market is estimated to reach US
  ..million by the year 2018, and would reach US
  ..million by the year 2025, recording growth at a
  CAGR of .. for the period spanning 2018-2025.
• The global ATTR patient population is anticipated
  to reach ..thousand by the year 2025, increasing
  from ..thousand in the year 2018, recording
  growth at a CAGR of .. for the period spanning
  2018-2025.
• It is expected that by the year 2025, the U.S.
  would held the largest market share of ..
  followed by Europe and ROW with .. shares
  respectively.

Global ATTR Market Value by Region
(2018/2025)
Global ATTR Market Forecast by Patient Volume
(2018-2025)
2025
2018
4
Accelerating economic growth and development
of new biological drugs will drive the market for
ATTR globally..
The U.S. ATTR Market Forecast by Value
(2018-2025)

• The U.S. ATTR market is expected to reach US
  ..million by the year 2018, and would reach US
  ..million by the year 2025, recording growth at a
  CAGR of .. for the period spanning 2018-2025.
• The U.S. ATTR patient population is anticipated
  to reach ..thousand by the year 2025, increasing
  from ..thousand in the year 2018. The patient
  population is expected to grow at a CAGR of ..
  for the period spanning 2018-2025.
• In Europe, ATTR market is expected to reach US
  ..million by the year 2019, and is further
  anticipated to reach US ..million by the year
  2025, recording growth at a CAGR of .. for the
  period spanning 2019-2025.

Europe ATTR Market Forecast by Value
(2019-2025)
T The U.S. ATTR Market Forecast by Patient
Volume (2018-2025)
5
For Report Purchase Click Belowhttp//www.koncep
tanalytics.com/Researchreport/global-transthyretin
-amyloidosis-attr-market-industry-analysis-outlook
-2018-2025-23454.aspx
Disclaimer
Contact Us
This is a licensed product of Koncept Analytics.
You cannot reproduce, publish, distribute,
publicly display, sell or create other works from
this report or use them in any way for commercial
purpose without our prior permission. Further,
you cannot copy this material, by any means
(including electronic copies), for distribution
to others unless you have purchased the corporate
license of this report. We believe the sources
are reliable, but Koncept Analytics does not
warranty the accuracy or completeness of the
data. The data presented in the report is updated
at the publication date but is subject to change
at subsequent releases. All possible efforts have
been made to ensure accuracy of data. However,
investors should not completely rely on the
information given in this report and must make
decisions based on their own investment strategy,
risk management and capital adequacy.
Koncept Analytics CS-36, First Floor, Ansal
Plaza Vaishali, Ghaziabad, U.P. 201010 T
91-120-4130959 M 91-9811715635
vikas_at_konceptanalytics.com
www.konceptanalytics.com